Ovarian Serous Cystadenocarcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Serous Cystadenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors [Phase 1, Phase 2]
Phase 1/2 first-in-human open-label dose-escalation study of a CSP-targeting functional antibody in solid tumors completed.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of everolimus and letrozole in patients with recurrent hormone receptor-positive ovarian…
-
CLINICAL_TRIALS withdrawal · 2019-02-20Clinical Trial Update: Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating metformin hydrochloride with carboplatin and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer [NA]
A terminated clinical trial evaluated a triple antiemetic regimen (granisetron, aprepitant, and dexamethasone) to prevent chemotherapy-induc…
-
CLINICAL_TRIALS research · 2016-10-28Clinical Trial Update: Collecting Tumor Samples From Patients With Gynecological Tumors
A completed clinical trial update describing a study that collected tumor samples from patients with gynecologic tumors, sponsored by the Gy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-06-01Clinical Trial Update: Research Study in Patients With Advanced Ovarian Epithelial Cancer
A Gynecologic Oncology Group trial in advanced ovarian epithelial cancer was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for A6 in treating persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary perito…